Page last updated: 2024-09-03

iguratimod and Pancreatitis

iguratimod has been researched along with Pancreatitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hou, C; Huang, D; Li, Q; Miao, Y; Peng, Y; Shi, C; Zhu, X	1

Other Studies

1 other study(ies) available for iguratimod and Pancreatitis

Article	Year
Iguratimod (T-614) attenuates severe acute pancreatitis by inhibiting the NLRP3 inflammasome and NF-κB pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 119 Topics: Acute Disease; Amylases; Animals; Chromones; Cyclooxygenase 2; Cytokines; Inflammasomes; Inflammation Mediators; Lipase; Male; Mice, Inbred C57BL; Neutrophil Infiltration; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pancreas; Pancreatitis; Signal Transduction; Sulfonamides	2019

Article

Year

Iguratimod (T-614) attenuates severe acute pancreatitis by inhibiting the NLRP3 inflammasome and NF-κB pathway.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 119

Topics: Acute Disease; Amylases; Animals; Chromones; Cyclooxygenase 2; Cytokines; Inflammasomes; Inflammation Mediators; Lipase; Male; Mice, Inbred C57BL; Neutrophil Infiltration; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pancreas; Pancreatitis; Signal Transduction; Sulfonamides

2019